Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2009 Apr 27.
Published in final edited form as: Urology. 2007 Apr;69(4):748–753. doi: 10.1016/j.urology.2006.12.022

Health behaviors and depressive symptoms in testis cancer survivors

EH Shinn 1, K Basen-Engquist 1, B Thornton 2, P E Spiess 3, L Pisters 3
PMCID: PMC2674069  NIHMSID: NIHMS22533  PMID: 17445663

Abstract

Objectives

Testis cancer has one of the highest 5-year survival rates of all cancer sites. The survival period is marked by increased risk for secondary cancer and cardiovascular events due to treatment related toxicities. The purposes of this cross-sectional study were to determine the prevalence of health behaviors and depressive symptoms and to assess the relationship between depression and health behaviors.

Methods

162 testis cancer survivors 2 to 10 years post-diagnosis completed a one-time phone interview. The interview included a battery of questions from the BRFSS assessing health behaviors (smoking, physical activity, cholesterol screening, colorectal cancer screening, alcohol consumption, and fruit and vegetable intake) as well as the CES-D assessing depressive symptoms.

Results

The interviews revealed low prevalences of health behaviors among testis cancer survivors. The percentage of testis cancer survivors who scored above the cutoff on the CES-D, 17.5%, was higher than large-scale population-based estimates in males aged 19–44, 11%. Smoking was significantly related to depression. Depressive symptoms (CES-D score) differed significantly depending on smoking status (current smokers, M=15.2; former smokers, M=6.2, p<.001; and never smokers, M=8.7, p<.001).

Conclusions

Given the increased risk of cancer and treatment-related morbidities of these survivors, the findings of this study suggest that health care professionals should encourage testis cancer survivors to engage in health behaviors and check for depressive symptoms.

Keywords: Smoking, cholesterol screening, colorectal cancer screening, alcohol, diet, physical activity, depression, cancer survivor, testicular cancer

Introduction

Testis cancer has one of the highest 5-year overall survival rates, 95.5% of all malignancies.1 Since incidence is highest among 15 to 39 yr olds, the period of survivorship for testis cancer is longer than that of most other groups of cancer survivors. However, long-term testis cancer survivors (TCS) who were treated with cisplatin-based chemotherapy have an increased observed-to-expected (O/E) ratio of 1.4 for secondary neoplasia2 and an increased O/E ratio ranging from 2.43 to 7.14 for cardiovascular morbidities. Behavioral factors such as smoking, diet, alcohol consumption, and cancer screening represent an important pathway for disease prevention5, 6. Unfortunately, little is known about TCS’ health beahviors. 7

Depression may be an important determinant in health behaviors for cancer survivors. In a Norwegian study with 1260 long-term TCS, participants who identified themselves as physically active were 44% less likely to be depressed, compared with physically inactive participants8. Studies with other cancer survivors have shown an inverse relationship between depression and various health behaviors, such as diet7, 9 and physical activity10. In non-cancer patient samples, meta-analytic and epidemiologic reviews have shown depression to be an important independent risk factor associated with tobacco use, alcohol abuse, sedentary lifestyle, and increased dietary fat consumption1115.

Our cross-sectional study investigated whether depressive symptoms were associated with various health behaviors in a cancer survivor sample who were two-to-ten years post-diagnosis. Tobacco and alcohol consumption, colorectal cancer and cholesterol screening behaviors, physical activity level, and fruit and vegetable consumption were assessed. It was hypothesized that for each of these types of health behaviors, TCS who engaged in the unhealthy form of the behavior would have higher depressive symptomatology than those who engaged in the healthy form.

Material and Methods

Background Study

Between January 2000 and June 2002, data were collected as part of a larger cross-sectional study assessing quality of life concerns among 162 TCS two-to-ten yrs post-diagnosis.

Study Design and Sample

Participants for the study (n=162) were eligible if they were: 1) aged 18–80, 2) diagnosed with seminomatous or non-seminomatous germ-cell testis cancer between two-to-ten yrs prior to evaluation, 3) residing in the U.S., and 4) able to give informed consent. Four hundred and forty-one potential participants were identified using a list of testis cancer patients previously treated at the M. D. Anderson Genitourinary Center. Of these, 212 patients were unable to be contacted due to incorrect addresses or phone numbers (five attempts were made to reach the patient before stopping). From the remaining list, 229 patients were approached either in person during their follow-up appointments at the Center or via letter and telephone if they were not followed at M. D. Anderson. Of these, 37 refused. The remaining patients agreed to participate and were consented (telephone consenters were mailed a consent form and return envelopes), yielding a participation agreement rate of 83.8% of reachable survivors. Of the 192 consented participants, 162 completed the questionnaire battery via a structured telephone interview with a trained master’s-level study coordinator. The structured interviews were scheduled mostly during the evenings and weekends in order to maximize completion rates.

Measures

Depression was measured as a continuous variable using the Centers for Epidemiological Studies- Depression (CES-D).16 Demographics were age (years), race (White or non-White), education (highest grade level), employment (currently working or student status, versus unemployed, retired, or unable to work), and income (collapsed into 6 levels, see Table 1).

Table 1.

Demographics

Characteristic Mean Std. Dev. Frequency %
Time since Treatment (yrs) 4.5 1.6 Range= 2.2 to 9.6 yrs
Seminomatous 53 33
 Nonseminomatous 109 67
Stage at diagnosis
 I 50 31
 II A/B/C 58 36
 III 15 9
Type of Treatment
 Surgery only 2 1
 Surgery and radiation 38 29
 Surgery and chemo 80 61
 Surgery, radiation, and chemo 11 8
Age (yrs) of Participants 37.2 9.0 Range =20 to 59 yrs
Age of Participants At Time of Dx 32.1 8.6
Age of Unreachable Survivors at Time of Diagnosis 29.2 8.6
Age (years)
 20’s 35 22
 30’s 65 40
 40’s 46 28
 50’s 14 9
Race of Participants
 White 141 87
 African-American 2 1
 Asian/Pacific Islander 1 .6
 American Indian/Alaska Native 3 2
 Hispanic 15 9
 Other 0 0
Race of Unreachable Survivors
 White 158 74
 African-American 5 2.6
 Other 1 0
 Spanish Surname 46 23.1
 Missing 2
Education
 Some high school (grades 9–11) 8 5
 Grade 12 or GED 25 15
 Some college (1–3 yrs) 46 28
 College and above (4 yrs or more) 83 51
Household Income
 $15,000 annually or less 9 6
 $16,000 to $24,000 annually 18 11
 $25,000 to $34,000 annually 18 11
 $35,000 to $49,000 annually 17 11
 $50,000 to $74,000 annually 29 18
 $75,000 or more annually 67 41
Marital status
 Married or living with partner 92 65
 Not married or living with a partner 49 35
 Missing 1 1
Unreachable Survivors
 Married or living with partner 95 50
 Not married or living with a partner 94 50
Work Status
 Employed for wages 123 76
 Student 9 6
 Out of work 7 5
 Retired/Stay at home 3 2
 Unable to work 2 1

Clinical variables were employed as control variables in the ANOVA: Time since diagnosis was measured as a continuous variable in years. Type of tumor was dichotomized into seminomatous and non-seminomatous type. Stage was categorized into five levels, I, IIa, IIb, IIc, and III.

The following items from the 1999 CDC Behavioral Risk Factor Surveillance Survey have demonstrated moderate-to-high reliability and validity 17. Smoking was categorized into three levels, current smoker, former smoker, and never smoker. Physical activity was assessed by measuring the number of minutes, distance (if applicable), speed, and intensity for each leisure physical activity (LPA) volunteered, then categorized into four levels (sedentary, irregular, regular moderate, regular vigorous; see Table 2). The cholesterol screening variable consisted of BRFSS items asking about the recency of blood cholesterol screening and was categorized into two levels (within the past year, more than a year or never). Alcohol consumption was measured in three different ways: 1) Percentage who used alcohol in the past month; 2) Number of Drinks per occasion; and 3) Problem Drinking episodes in the past month. Daily fruit and vegetable servings was derived from a series of questions about intake frequency of green salad, fruits, fruit juices, vegetables, and dichotomized as 5 or more versus less than 5 per day. Due to their low frequency, Colorectal Cancer screening behaviors were collapsed into an index variable dichotomizing whether home blood stool kits or sigmoidoscopy or colonoscopy were ever done.

Table 2.

ANOVA results regressing health behaviors onto depressive symptom scores*

Behavior N Behavior Categories Adjusted Mean for Depression Level* Standard Error P value
Physical activity levels 119
20 Physically inactive 10.7 2.1 .85
33 Irregular activity 9.9 1.6
47 Regular activity 8.6 1.3
19 Regular vigorous activity 9.2 2.2
≤ 5 Fruits and Veg/Day 119
105 Less than 5 a day 9.9 .9 .09
14 5 or more per day 5.2 2.6
Drank 5+drinks/past mth 90
48 Zero times past mth 8.5 1.3 .23
18 1 time past mth 12.4 2.1
24 2 + times past mth 7.7 1.8
Average number of drinks/past mth 119
29 0 drinks 8.5 1.8 .12
11 1 drink 3.5 2.8
35 2 drinks 10.9 1.6
44 3 or more 10.3 1.4
Average number of drinking occasions/past mth 90
48 0 times past mth 8.6 1.3 .75
36 1–5 occasions past mth 9.3 1.5
6 5 or more occasions past mth 11.5 3.9
Cancer Screening (Blood Stool test, sigmoidoscopy or colonoscopy) 47
27 Ever performed 9.8 2.1 .82
20 Never performed 9.1 1.8
Checking Blood Cholesterol 76
54 Within the past 12 months 10.9 1.2 .07
22 Never or more than 1 yr 4.9 1.9
Smoker 119
23 Current 15.2 2.0 .005**
24 Former 6.2 1.9
72 Never 8.7 1.1
*

After controlling for age, race, education, income, working status, type of malignancy, BMI, stage at diagnosis, and time since diagnosis

**

Significant at p<.01 level. Tukey’s post-hoc indicated current smokers were significantly different from former and from never smokers. Former and Never smokers were not significantly different..

Analysis

A one-way analysis of variance (ANOVA) was utilized to determine whether the TCS who engaged in the unhealthy behavior of interest had significantly higher levels of depressive symptoms compared with survivors who engaged in the healthy behavior of interest, controlling for demographic and medical data. Separate one-way ANOVAs were conducted for each behavior of interest (smoking, physical activity, alcohol consumption, daily fruit and vegetable intake, and cancer screening) to determine whether they were significantly associated with level of depressive symptoms. With the exception of the cholesterol screening analysis, all of the ANOVAs controlled for age, race, BMI, educational level, income level, stage of disease, histologic type (seminomous vs. non-seminomatous), and time since diagnosis. Since patients with a history of hypercholesteremia would be more likely to engage in cholesterol screening, having been told of high blood cholesterol was added as a covariate for the cholesterol analysis only. Post-hoc contrast tests for significant ANOVA findings used a Tukey’s correction.

Results

The demographics of the sample are presented in Table 1. The mean age was 37.2 yrs, and the majority of the sample (87%) were white and 9% were Hispanic. Most of the men (65%) were married, and just over half had completed four years of college or more (51%). Analyses comparing the medical and demographic characteristics of the 162 participants versus the 212 unreachable survivors revealed no differences between the two groups in disease stage (p=.35) or histology at time of last contact (p=.28). Compared with our participants, unreachable survivors tended to be younger at the time of diagnosis (p=.002), non-married (χ2 =.003), non-white ((χ2 =.002).

Prevalence of depression

The prevalence of TCS in the sample who scored above the traditional cutoff of 16 on the CES-D was 17.9% (M=9.4 ± 9.5).

Prevalence of health behaviors

Survivors’ self-reported practice of health behaviors was low overall. Regarding physical activity, 18% were sedentary, 27.8% had irregular (less than 20 min) activity less than 3X/wk, 38.9% engaged in regular, moderate activity for at least 20 min, 3X/wk or more, and 15% had 20 min or more of regular, vigorous intensity exercise, 3X/wk or more. The prevalence of those who reported eating five or more servings of fruits and vegetables a day was 11%. Forty-five percent reported having their blood cholesterol checked within the past year and 20% had checked it within the last five years. Survivors aged 40 and above who reported having any of three types of cancer screening tests done within the past five years was low (41% for any of the three tests; prevalence of ever performing a home blood stool kit was 26%, sigmoidoscopy, 24%, and colonoscopy, 11%).

Prevalence of risk behaviors

Nineteen percent of the survivors reported current smoking and 20% reported being former smokers. The percentage of participants who reported using alcohol within the past month was 75.6%, while average drinks consumed per occasion was 2.4. Forty-six percent reported at least one problem drinking episode of drinking 5 or more drinks on one occasion in the past month.

Depressive symptoms and health behaviors (see Table 2)

After controlling for the demographics and clinical variables, there were no significant differences in depression between those who screened for cholesterol in the past yr versus those who did not.

Depressive symptoms and risk behaviors

After controlling for the demographic and medical variables mentioned previously, smoking status (current, former or never smokers) had significantly different levels of depressive symptoms than each other. Post-hoc analysis showed that current smokers had significantly higher levels of depressive symptoms on the CES-D compared with former and never smokers.

Comment

Prevalence of depressive symptoms

Our study found that 17.5% scored above the cutoff on the CES-D, which is much higher than the prevalence reported for U.S. males aged 19–44 in population-based studies 11%18. Similarly, 21.9% of 83 Japanese TCS who were 1– 28 yrs post-treatment scored as depressed on a single 4-point item19. In contrast, in a large cooperative Norwegian study by Dahl et al., only 9.7% of 1,408 TCS who were 4 to 22 yrs post-treatment scored above the HADS cutoff, and this prevalence was slightly lower than that of their study’s community-based control group20. One potential reason for the higher depression level in our sample is that our sample tended to have a higher proportion of nonseminomatous tumor type, which tends to have a more serious prognosis, (67.3%) compared with Dahl et al (50.1%). In turn, a higher proportion of our sample (69% vs 38.5% in the Dahl et al. study) received chemotherapy in addition to surgery, which tends to be more aggressive than protocols without chemotherapy.

Prevalence of health behaviors

Overall, the prevalences of health behaviors in this sample of long-term TCS were low. Regarding physical activity, roughly half of the survivors in our sample were engaging in regular exercise of at least moderate intensity, which is comparable with Thorsen et al.’s analysis of the same previously-mentioned cooperative Norwegian parent study. Thorsen et al. also analyzed data from the same cooperative Norwegian parent study and found that 43% of 1,276 TCS reported engaging in 60–120 min of hard physical activity per week on the average21. While this is a much higher prevalence than our prevalence of 15% who engaged in vigorous activity for at least 20 min, 3X/wk, it should be noted that Thorsen et al. employed a single 4-point item to measure LPA whereas our calculations were derived from a structured interview.

Prevalence of Risk behaviors

Nineteen percent of the TCS in the current study reported current smoking, which was similar to the range of 17–18.6% found in van den Belt-Dusebout’s study of 2,512 Dutch 5-yr TCS22, but lower than that found in Arai et al.’s study of 83 Japanese TCS, 38.5% 19. The Norwegian studies using the cooperative database also reported higher prevalences of current smoking, 35.1% 23 and 39.1% 8, depending on the subsample analyzed. The higher educational level in the current study sample may account for the lower smoking rate (51% with at least a bachelor’s level vs 19.8% in Thorsen et al.; educational data was unavailable for the Arai et al. and van den Belt-Dusebout et al.’s studies).

It is rare for a study of any type of cancer survivor, let alone TCS, to report alcohol use. The only relevant finding in the TCS literature was reported by Dahl et al. who measured problem drinking with a 4-item AUDIT20. Twenty-two percent scored above the cutoff on the AUDIT. In our study, 46.6% answered affirmatively to our single-item problem drinking measure, i.e. having 5 or more drinks at a time. However, comparison of these two findings is difficult since our study’s problem drinking measure used a different time frame.

Depressive symptoms and health behaviors

Contrary to our expectations, none of the health behaviors were associated with depressive symptom levels in our study. Our finding that depression was not related to physical activity level was in direct contrast to Thorsen et al.’s finding that physically active TCS had a 44% lower risk of being classified as depressed compared with inactive TCS8. To our knowledge, other studies with TCS have not assessed the relationship between depression with diet, cancer and cholesterol screening. The generalizability of our nonsignificant relationship between depression and cholesterol and colorectal cancer screening may be constrained by the low power of these analyses (n=76 and 47, respectively).

Depressive symptoms and risk behaviors

To our knowledge, the relationships between smoking and alcohol use with depression have not been assessed with other cancer survivors. Therefore, we will relate our current findings to the extant literature where relevant. That smoking status was positively related with depression is consistent with the large epidemiological literature delineating the relationship between various smoking behaviors and negative affect.11, 24, 25 However, our negative findings regarding alcohol use and depression is inconsistent with national surveys finding strong comorbid relationships between depressive symptom level and DSM diagnoses 26. The lower completion rates for the alcohol measures may have underpowered these analyses.

Limitations

Since the study was cross-sectional, the directionality of the association between depression and smoking could not be determined. Prospective studies are needed to yield etiologic information regarding mood determinants of health behaviors in cancer survivors. Second, the typical demographic profile of patients treated at M. D. Anderson Cancer Center tends to be white, well-educated, and relatively wealthy. It is largely unknown how this compares with population-based demographics of TCS since SEER does not currently collect SES information. However, comparison with SEER indicated similar ethnic breakdowns27. Finally, the number of unreachable eligible survivors was approximately 52%, which was a reflection of the young age group of the sample. Our success rate in reaching TCS who were 2 to 10 yrs post-treatment is typical of the follow-up literature in testis cancer. For example, Huddart et al. successfully contacted 680 of 1363 testis cancer patients (49.9%) known to be alive at follow up 5 yrs post-treatment.3

Conclusions

Our study presents prevalence estimates for health behaviors rarely reported in the cancer survivor literature, including cholesterol screening, colorectal cancer screening, and alcohol use. These health behaviors were collected by a trained interviewer using valid items from the BRFSS to measure several parameters for most of the health behaviors: e.g. for physical activity, frequency, intensity and duration were calculated for each type of activity. Given TCS’ heightened risks for cardiovascular morbidities and recurrent disease, the rates of healthy behaviors in our sample were alarmingly low. Physicians should encourage preventive health behaviors and be vigilant for signs of depression in testis cancer survivors. In our sample, nearly one in five TCS had a clinically significant level of depressive symptoms. While the CES-D is not a casefinding proxy for treatable depressive episodes, it is nonetheless a significant indicator of distress warranting further follow-up.

Our study directly addresses two research areas targeted by the November 2005 IOM report on cancer survivors, prevention and psychosocial concerns (specifically in this study the problem of depressive symptoms)28. In our study, depression was not a key variable associated with health behaviors, with the exception of smoking. The lack of relationship between depression and various health behaviors provides an important contribution to the growing literature examining the complex, independent, and predictive role that depression plays in cardiovascular endpoints in community and cancer samples.29, 30

Acknowledgments

We would like to thank Lindsay Hayler for her editorial assistance.

Funding Considerations

NCI R03-CA-3348, NCI K07-CA-093512

Footnotes

Conflicts of Interest

None

Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

References

  • 1.Society AC. Cancer Facts & Figures 2004. Atlanta: American Cancer Society, Inc.; 2004. [Google Scholar]
  • 2.Travis L, Curtis R, Storm H, Hall P, Holowaty E, Van Leeuwen F, et al. Risk of second malignant neoplasms among long-term survivors of testicular cancer. Journal of the National Cancer Institute. 1997;89(19):1429–39. doi: 10.1093/jnci/89.19.1429. [DOI] [PubMed] [Google Scholar]
  • 3.Huddart RA, Norman A, Shahidi M, Horwich A, Coward D, Nicholls J, et al. Cardiovascular disease as a long-term complication of treatment for testicular cancer. Journal of Clinical Oncology. 2003;21(8):1513–23. doi: 10.1200/JCO.2003.04.173. [DOI] [PubMed] [Google Scholar]
  • 4.Meinardi M, Gietema J, van der Graaf W, van Veldhuisen D, Runne M, Sluiter W, et al. Cardiovascular morbidity in long-term survivors of metastatic testicular cancer. Journal of Clinical Oncology. 2000;18:1725–32. doi: 10.1200/JCO.2000.18.8.1725. [DOI] [PubMed] [Google Scholar]
  • 5.Austoker J. Cancer prevention in primary care: cancer prevention: setting the scene. BMJ. 1994;308(6941):1415–20. doi: 10.1136/bmj.308.6941.1415. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Byers T, Anda R, McQueen D, Williamson D, Mokdad A, Casper M, et al. The correspondence between coronary heart disease mortality and risk factor prevalence among states in the United States, 1991–1992. Preventive Medicine. 1998;27:311–16. doi: 10.1006/pmed.1998.0303. [DOI] [PubMed] [Google Scholar]
  • 7.Tangney C, Young J, Murtaugh M, Cobleigh M, Oleske D. Self-reported dietary habits, overall dietary quality and symptomatology of breast cancer survivors: a cross-sectional examination. Breast Cancer Research and Treatment. 2002;71:113–23. doi: 10.1023/a:1013885508755. [DOI] [PubMed] [Google Scholar]
  • 8.Thorsen L, Nystad W, Stigum H, Dahl O, Klepp O, Bremnes R, et al. The association between self-reported physical activity and prevalence of depression and anxiety disorder in long-term survivors of testicular cancer and men in a general population sample. Supportive Care in Cancer. 2005;13:637–46. doi: 10.1007/s00520-004-0769-0. [DOI] [PubMed] [Google Scholar]
  • 9.Maunsell E, Drolet M, Brisson J, Robert J, Deschenes L. Dietary change after breast cancer: extent, predictors, and relation with psychological distress. Journal of Clinical Oncology. 2002;20:1017–25. doi: 10.1200/JCO.2002.20.4.1017. [DOI] [PubMed] [Google Scholar]
  • 10.Segar M, Katch V, Roth R, Garcia A, Portner T, Glickman S, et al. The effect of aerobic exercise on self-esteem and depressive and anxiety symptoms among breast cancer survivors. Oncology Nursing Forum. 1998;25:107–13. [PubMed] [Google Scholar]
  • 11.Anda R, Williamson D, Escobedo L, Mast E, Giovino G, Remington P. Depression and the dynamics of smoking: a national perspective. JAMA. 1990;264:1541–45. [PubMed] [Google Scholar]
  • 12.Farmer M, Locke B, Moscicki E, Dannenberg A, Larson D, Radloff LS. Physical activity and depressive symptoms: the NHANES I epidemiologic follow-up study. American Journal of Epidemiology. 1988;128(6):1340–51. doi: 10.1093/oxfordjournals.aje.a115087. [DOI] [PubMed] [Google Scholar]
  • 13.Steptoe A, Wardle J, Fuller R, Holte A, Justo J, Sanderman R, et al. Leisure-time physical exercise: prevalence, attitudinal correlates, and behavioral correlates among young europeans from 21 countries. Preventive Medicine. 1997;26:845–54. doi: 10.1006/pmed.1997.0224. [DOI] [PubMed] [Google Scholar]
  • 14.Wang L, van Belle G, Kukull W, Larson E. Predictors of functional change: a longitudinal study in non-demented people aged 65 and over. Journal of the American Geriatric Society. 2002;50:1525–34. doi: 10.1046/j.1532-5415.2002.50408.x. [DOI] [PubMed] [Google Scholar]
  • 15.Grant BF, Harford TC. Comorbidity between DSM-IV alcohol use disorders and major depression: results of a national survey. Drug and Alcohol Dependence. 1995;39:197–206. doi: 10.1016/0376-8716(95)01160-4. [DOI] [PubMed] [Google Scholar]
  • 16.Hann D, Winter K, Jacobsen P. Measurement of depressive symptoms in cancer patients: evaluation of the Center for Epidemiological Studies Depression Scale (CES-D) Journal of Psychosomatic Research. 1999;46:437–43. doi: 10.1016/s0022-3999(99)00004-5. [DOI] [PubMed] [Google Scholar]
  • 17.Nelson D, Holtzman D, Bolen J, Stanwyck C, Mack K. Reliability and validity of measures from the Behavioral Risk Factor Surveillance System (BRFSS) Soz Praventivmed. 2001;46(Suppl I):S32–42. [PubMed] [Google Scholar]
  • 18.Sayetta R, Johnson D. United States, 1974–75. U.S. Department of Health, Education, and Welfare; 1980. Basic data on depressive symptomatology. [DOI] [PubMed] [Google Scholar]
  • 19.Arai Y, Mutsushi K, Hida S, Terachi T, Okada Y, Yoshida O. Psychosocial aspects in long-term survivors of testicular cancer. Journal of Urology. 1996;155:574–78. [PubMed] [Google Scholar]
  • 20.Dahl A, Haaland C, Mykletun A, Bremnes R, Dahl O, Klepp O, et al. Study of anxiety disorder and depression in long-term survivors of testicular cancer. Journal of Clinical Oncology. 2005;23(10):2389–95. doi: 10.1200/JCO.2005.05.061. [DOI] [PubMed] [Google Scholar]
  • 21.Thorsen L, Nystad W, Dahl O, Klepp O, Bremnes R, Wist E, et al. The level of physical activity in long-term survivors of testicular cancer. European Journal of Cancer. 2003;39:1216–21. doi: 10.1016/s0959-8049(03)00151-5. [DOI] [PubMed] [Google Scholar]
  • 22.van Den Belt-Dusebout A, Nuver J, de Wit R, Gietema J, ten Bokkel Huinink W, Rodrigus P, et al. Long-Term risk of cardiovascular disease in 5-yr survivors of testicular cancer. Journal of Clinical Oncology. 2005;24(3):467–75. doi: 10.1200/JCO.2005.02.7193. [DOI] [PubMed] [Google Scholar]
  • 23.Sagstuen H, Aass N, Fossa S, Dahl O, Klepp O, Wist E, et al. Blood pressure and body mass index in long-term survivors of testicular cancer. Journal of Clinical Oncology. 2005;23(22):4980–90. doi: 10.1200/JCO.2005.06.882. [DOI] [PubMed] [Google Scholar]
  • 24.Friedman G. Depression, smoking, and lung cancer. American Journal of Epidemiology. 1996;144:1104–06. doi: 10.1093/oxfordjournals.aje.a008888. [DOI] [PubMed] [Google Scholar]
  • 25.Glassman A, Helzer J, Covey L, Cottler L, Stetner F, Tipp J, et al. Smoking, smoking cessation, and major depression. JAMA. 1990;264:1546–49. [PubMed] [Google Scholar]
  • 26.Lipton R, Nilssen O. Relating alcohol use and mood: results from the Tromso Study. Journal of Studies on Alcohol. 1999;60:111–22. doi: 10.15288/jsa.1999.60.111. [DOI] [PubMed] [Google Scholar]
  • 27.Ries L, Harkins D, Krapcho M, et al., editors. Institute NC. SEER Cancer Statistics Review, 1975–2003. Bethesda, MD: 2006. http://seer.cancer.gov/csr/19752003/, based on November 05 SEER data submission, posted to the SEER Website, 06. [Google Scholar]
  • 28.Hewitt M, Greenfield S, Stovall E. Executive Summary. Institute of Medicine; 2005. From Cancer Patient to Cancer Survivor: Lost in Transition. [Google Scholar]
  • 29.Gump B, Matthews KA, Eberly LE, Chang YF. Depressive symptoms and mortality in men. Results from the Multiple Risk Factor Intervention Trial. Stroke. 2005;36:98–102. doi: 10.1161/01.STR.0000149626.50127.d0. [DOI] [PubMed] [Google Scholar]
  • 30.Ford DE, Mead LA, Chang PP, Cooper-Patrick L, Wang NY, Klag MJ. Depression is a risk factor for coronary artery disease in men: the Precursors Study. Archives of Internal Medicine. 1998;158(13):1422–26. doi: 10.1001/archinte.158.13.1422. [DOI] [PubMed] [Google Scholar]

RESOURCES